• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改善静脉性腿部溃疡愈合的药物治疗:文献综述

A Literature Review of Pharmacological Agents to Improve Venous Leg Ulcer Healing.

机构信息

Barry University School of Podiatric Medicine, Miami Shores, FL.

出版信息

Wounds. 2020 Jul;32(7):195-207.

PMID:33166265
Abstract

Compression therapy is the gold standard treatment for venous leg ulcers (VLUs); however, with adjunctive pharmacological therapies and poor patient adherence using compressive dressings, clinicians are looking to find the advantage in treating VLUs. This literature review focuses on the efficacy of pharmacological agents, quality of life using agents in addition to compression therapy, and cost effectiveness to indicate the best outcomes for pharmacological treatment of VLUs. The following available venotonic, hemorheologic, and fibrinolytic agents were reviewed for oral management in treating VLUs: pentoxifylline, flavonoids (diosmin, hidrosmin, rutosides, and micronized purified flavonoid fraction, Vasculera), Red-Vine-Leaf-Extract AS 195, Ruscus, Ginkgo biloba, Centella asiatica, Pycnogenol (French maritime pine bark), escin/horse chestnut extract, nutritional supplements (ie, zinc and magnesium, glycosaminoglycans [sulodexide], mesoglycans), Axaven, cilostazol, fibrinolytic enhancers (stanozolol and defibrotide), calcium dobesilate, aspirin, antibiotics (antimicrobials, doxycycline, levamisole), diuretics, cinnarizine, naftazone, and benzarone. Venous leg ulcer pharmacological treatment options were searched in the English language from February 2020 to March 2020 using numerous databases and sites, such as PubMed. Drugs used adjunctively with compression therapy that facilitate healing in long-standing or large VLUs include micronized purified flavonoid fraction, pentoxifylline, sulodexide, and mesoglycan.

摘要

压迫疗法是治疗静脉性腿部溃疡(venous leg ulcers,VLU)的金标准治疗方法;然而,由于附加的药理学治疗和患者对压迫性敷料的依从性差,临床医生正在寻找治疗 VLU 的优势。本文综述重点关注药理学治疗的疗效、药物治疗联合压迫疗法对生活质量的影响以及成本效益,以确定治疗 VLU 的最佳药理学治疗方案。本文对以下可用的静脉活性、血液流变学和纤维蛋白溶解剂进行了评估,以探讨其在治疗 VLU 中的口服管理:己酮可可碱、黄酮类(地奥司明、羟苯磺酸、芦丁、米诺环素和微粉化纯化黄酮类)、红葡萄叶提取物 AS 195、鼠尾草、银杏叶、积雪草、碧萝芷(法国松树皮提取物)、七叶皂苷/欧洲七叶树提取物、营养补充剂(如锌和镁、糖胺聚糖[舒洛地特]、弥凝)、Axaven、西洛他唑、纤维蛋白溶解增强剂(司坦唑醇和达肝素)、羟苯磺酸钙、阿司匹林、抗生素(抗菌药、多西环素、左旋咪唑)、利尿剂、桂利嗪、萘呋唑酮和苯扎酮。本研究于 2020 年 2 月至 2020 年 3 月间,通过使用包括 PubMed 在内的多个数据库和网站,以英语搜索静脉性腿部溃疡的药理学治疗选择。与压迫疗法联合使用以促进慢性或大 VLU 愈合的药物包括米诺环素、己酮可可碱、舒洛地特和弥凝。

相似文献

1
A Literature Review of Pharmacological Agents to Improve Venous Leg Ulcer Healing.改善静脉性腿部溃疡愈合的药物治疗:文献综述
Wounds. 2020 Jul;32(7):195-207.
2
The Most Severe Stage of Chronic Venous Disease: An Update on the Management of Patients with Venous Leg Ulcers.慢性静脉疾病最严重阶段:静脉性腿部溃疡患者管理的最新进展。
Adv Ther. 2020 Feb;37(Suppl 1):19-24. doi: 10.1007/s12325-020-01219-y. Epub 2020 Jan 22.
3
Venous leg ulcers.下肢静脉溃疡
BMJ Clin Evid. 2011 Dec 21;2011:1902.
4
Venous leg ulcers.下肢静脉溃疡
BMJ Clin Evid. 2008 Sep 15;2008:1902.
5
Systematic literature review and network Meta-analysis of sulodexide and other drugs in chronic venous disease.系统文献回顾和网络荟萃分析:舒洛地特与其他药物治疗慢性静脉疾病的疗效比较。
Phlebology. 2021 Oct;36(9):695-709. doi: 10.1177/02683555211015020. Epub 2021 May 13.
6
A Meta-analysis to Compare Four-layer to Short-stretch Compression Bandaging for Venous Leg Ulcer Healing.一项比较四层与短拉伸加压绷带用于腿部静脉溃疡愈合的荟萃分析。
Ostomy Wound Manage. 2018 May;64(5):30-37.
7
Efficacy and safety of pentoxifylline for chronic venous leg ulcers: study protocol for a multicenter randomized controlled trial in China (ESPECT study).己酮可可碱治疗慢性静脉性下肢溃疡的疗效和安全性:一项在中国多中心随机对照试验的研究方案(ESPECT 研究)。
Trials. 2023 Aug 2;24(1):491. doi: 10.1186/s13063-023-07547-y.
8
Chronic venous leg ulcers: is topical zinc the answer? A review of the literature.下肢慢性静脉溃疡:局部应用锌剂是解决之道吗?文献综述
Adv Skin Wound Care. 2014 Jan;27(1):35-44; quiz 45-6. doi: 10.1097/01.ASW.0000439173.79541.96.
9
Efficacy and Safety of 4% Hibiscus rosa-sinensis Leaf Extract Ointment as an Adjunct Treatment to Compression Stockings on the Closure of Venous Leg Ulcers: A Pilot Study.4%扶桑叶片提取物软膏辅助弹力袜治疗下肢静脉溃疡愈合的疗效及安全性:一项初步研究
Wounds. 2019 Sep;31(9):236-241. Epub 2019 Jun 30.
10
Randomised, double blind, multicentre, placebo controlled study of sulodexide in the treatment of venous leg ulcers.舒洛地希治疗下肢静脉溃疡的随机、双盲、多中心、安慰剂对照研究
Thromb Haemost. 2002 Jun;87(6):947-52.

引用本文的文献

1
Rational Analysis of the Utilization of Pentoxifylline in a Tertiary Hospital: Central Hospital Affiliated to Shandong First Medical University.山东第一医科大学附属中心医院对己酮可可碱使用情况的合理性分析
Risk Manag Healthc Policy. 2025 Jul 9;18:2335-2350. doi: 10.2147/RMHP.S517679. eCollection 2025.
2
Preclinical Evidence That Mesoglycan Unfolds Complex Anti-Aging Effects in Photoaged Female Facial Skin.关于硫酸乙酰肝素在光老化女性面部皮肤中展现复杂抗老化作用的临床前证据。
Int J Mol Sci. 2025 Jun 17;26(12):5787. doi: 10.3390/ijms26125787.
3
Venous leg ulcer healing as a determinant of quality of life in patients treated with unna boot: A quasi-experimental study.
使用Unna靴治疗的患者中,下肢静脉溃疡愈合情况作为生活质量的决定因素:一项准实验研究。
PLoS One. 2025 Jan 29;20(1):e0314490. doi: 10.1371/journal.pone.0314490. eCollection 2025.
4
Modelling wound area in studies of wound healing interventions.模拟伤口愈合干预研究中的伤口面积。
BMC Med Res Methodol. 2024 Sep 16;24(1):206. doi: 10.1186/s12874-024-02326-y.
5
Bacterial Species Involved in Venous Leg Ulcer Infections and Their Sensitivity to Antibiotherapy-An Alarm Signal Regarding the Seriousness of Chronic Venous Insufficiency C6 Stage and Its Need for Prompt Treatment.与下肢静脉溃疡感染相关的细菌种类及其对抗菌治疗的敏感性——关于慢性静脉功能不全C6期严重性及其及时治疗必要性的警示信号
Microorganisms. 2024 Feb 26;12(3):472. doi: 10.3390/microorganisms12030472.
6
Association between venous leg ulcers and chronic heart failure: A Mendelian randomization study.静脉性腿部溃疡与慢性心力衰竭的关联:一项孟德尔随机研究。
Int Wound J. 2024 Feb;21(2):e14744. doi: 10.1111/iwj.14744.
7
Clinical evidence and rationale of mesoglycan to treat chronic venous disease and hemorrhoidal disease: a narrative review.聚糖在治疗慢性静脉疾病和痔病中的临床证据和原理:叙述性综述。
Updates Surg. 2024 Apr;76(2):423-434. doi: 10.1007/s13304-024-01776-9. Epub 2024 Feb 14.
8
Recent Updates on the Therapeutics Benefits, Clinical Trials, and Novel Delivery Systems of Chlorogenic Acid for the Management of Diseases with a Special Emphasis on Ulcerative Colitis.关于绿原酸在疾病治疗中的治疗功效、临床试验和新型给药系统的最新进展,特别强调溃疡性结肠炎。
Curr Pharm Des. 2024;30(6):420-439. doi: 10.2174/0113816128295753240129074035.
9
Flavonoids: Antiplatelet Effect as Inhibitors of COX-1.类黄酮:作为 COX-1 抑制剂的抗血小板作用。
Molecules. 2022 Feb 8;27(3):1146. doi: 10.3390/molecules27031146.
10
Nephroprotective Effects of Synthetic Flavonoid Hidrosmin in Experimental Diabetic Nephropathy.合成类黄酮水芹素对实验性糖尿病肾病的肾保护作用
Antioxidants (Basel). 2021 Nov 29;10(12):1920. doi: 10.3390/antiox10121920.